How Much Does Stock Analysis Software Cost? 2026 Price Table
July 14, 2026 · Agenttrading · Last updated July 14, 2026
- 1 THESIS
- 2 EVIDENCE
- 3 BACKTEST
- 4 RISK
- 5 VERDICT
02 EVIDENCE · FUNDAMENTALS
04 RISK · IN PLAIN ENGLISH
Past performance does not guarantee future results. Educational analysis only, not financial advice.
Stock analysis software costs between $0 and roughly $350 per month in July 2026, and almost everyone who is not a full-time trader belongs at the bottom of that range. Screeners run about $40 per month, research and data platforms $39 to $79, backtesting benches $19 to $55, and real-time scanners and charting engines $89 to $349. A capable, complete setup for a self-directed US investor costs about $60 per month total. The four-figure annual bills come from buying the wrong category, not from buying quality.
Below are the list prices, read off each vendor's own pricing page on July 14, 2026, plus the part the pricing page does not tell you: what the money actually buys, and where it is usually wasted.
Stock analysis software prices in 2026
| Tool | Category | Free tier | Entry price | Top consumer tier |
|---|---|---|---|---|
| Agenttrading | Backtesting bench | No | $19/mo | $129/mo |
| Portfolio Visualizer | Portfolio backtesting | Yes, limited | $30/mo billed annually | $55/mo billed annually |
| Finviz Elite | Screener | Yes, strong | $39.50/mo | $299.50/yr |
| Koyfin | Research platform | Yes, generous | $39/mo (Plus) | $79/mo (Premium) |
| Seeking Alpha | Research library | Basic articles | $299/yr (Premium, list) | $499/yr (Alpha Picks, list) |
| Trade Ideas | Real-time scanner | Limited | $89/mo (TI Basic) | $178/mo (TI Premium) |
| TrendSpider | Charting engine | No | $89/mo (about $52/mo annually) | $349/mo |
| ChatGPT and similar | General assistant | Yes | $20/mo (Plus, list) | Higher tiers exist |
List prices as published by each vendor on July 14, 2026. Promotional and annual discounts are routine in this category, particularly at Seeking Alpha and TrendSpider, so treat these as the anchor rather than the number you will pay. Vendors change prices; verify before you buy.
Why the same category ranges from $19 to $349
The price is set by one thing more than any other: real-time data. Live, exchange-fed quotes carry per-user licensing fees the vendor has to pass on, which is why real-time scanners and charting engines sit at the top of the table and end-of-day tools sit at the bottom. If your workflow does not require knowing the price this second, you are paying for a feed you do not use.
The second driver is depth of fundamentals history. Two years of financials is cheap; ten years plus estimates and ETF holdings is the exact line Koyfin draws between free and $39 per month, and that is a fair place to draw it.
The third driver is nothing at all, and it accounts for a surprising share of what people spend: features bought for the person you intend to become. The $349 charting tier is priced for someone who trades all day, and it is honestly priced for them.
What should a self-directed investor actually spend?
- Long-term investor, a few decisions a year: $0 to $19 per month. Free fundamentals from stockanalysis.com or the filings themselves, plus a bench when you want to test whether an allocation idea has ever held up. Anything more is a hobby expense, which is fine, as long as you call it that.
- Active self-directed investor, a few ideas a month: about $60 per month. A screener at roughly $40 to generate the shortlist, and a backtesting bench at $19 to find out whether the rule behind it ever worked. This pairing covers the whole loop and is the best value in the table.
- Fundamentals-heavy researcher: $39 to $79 per month for a research platform, because ten years of financials and estimates in one dashboard genuinely saves hours.
- Full-time day trader: $89 to $349 per month, and it is defensible, because real-time scanning and chart automation are the raw material of that job.
Note what happens to the percentages. A $2,136 annual scanner is an 8.5% hurdle on a $25,000 account before the strategy earns anything, and 0.4% on a $500,000 account. The same subscription is reckless in one account and trivial in the other.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
Is expensive stock analysis software worth it?
It is worth it when it changes decisions you were going to make anyway, and it is worth nothing when it does not, regardless of how good the product is. The test that survives contact with reality: name one decision the tool changed in the last 90 days. If you cannot name one, you are paying for the feeling of being equipped, and that feeling costs about $500 a year at the median price in this table.
The reverse is also true, and people underweight it. A $19 per month tool that stops you from putting $30,000 behind a strategy that never beat buy-and-hold has returned several years of its own cost in a single session. The cheapest software in the category is frequently the one with the highest return on spend, because killing one bad idea is worth more than surfacing ten good-looking ones.
Can you get stock analysis software for free?
Partly, and further than most people assume. SEC filings are free and authoritative. stockanalysis.com covers fundamentals well at no cost. Finviz's free screener is genuinely good. Koyfin's free tier includes charting, dashboards, and two years of financials. TradingView's free plan handles charts.
What no free tier gives you is a test. Nothing free will take your specific rule, run it across 20+ years of split- and dividend-adjusted daily prices with realistic trading costs charged, and tell you honestly that it underperformed. That is the paid step in this category, and it is also the step with the clearest link to money kept. A sensible starting configuration is free data plus one paid bench.
Are these subscriptions tax deductible?
For most individual investors in the US, no. The miscellaneous itemized deduction for investment expenses, which once covered research subscriptions, was suspended by the Tax Cuts and Jobs Act and remains unavailable to ordinary investors. If you trade through a business entity or qualify for trader tax status, research software can be an ordinary and necessary business expense, but that status has real requirements and is not a box you simply tick. If you do run through an entity, your accountant will want the year's spending organized rather than scattered across a dozen receipts, which is a five-minute job once your exported bookkeeping data is turned into clean, board-ready financial statements. Check with a CPA before you assume a deduction, because getting this wrong is more expensive than every subscription in the table combined.
The short answer
How much does stock analysis software cost? Budget about $60 per month for a complete self-directed setup in 2026: roughly $40 for a screener to find candidates and $19 for a bench to test whether the rule behind them ever worked. Real-time scanners and charting engines cost $89 to $349 per month and are worth it only if you trade for a living. Research platforms sit at $39 to $79. Everything above that line is a professional tool priced for a professional workload.
Agenttrading is the $19 end of that arithmetic, and it does one job well: you type a thesis in plain English, it restates the rule and shows it before running, tests it on 20+ years of adjusted daily data with a 0.1% cost per trade assumed by default, and stamps an honest verdict, including UNDERPERFORMED when the idea loses to simply holding.
The full category, priced and compared, is on best AI trading software. The testing engine is described on backtesting software, and whole-portfolio testing on portfolio backtesting. If you are deciding between specific vendors, the honest side-by-sides live on Koyfin alternative, Seeking Alpha alternative, and Finviz alternative, and do stock screeners work explains why the screener alone was never going to be enough.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.
Put it on the bench
Ideas are cheap. Verdicts take a bench.
Agenttrading restates your idea as a testable rule, backtests it on 20+ years of adjusted daily data, and explains the risks in plain English. Honest verdicts, even when the idea loses.
Past performance does not guarantee future results. For educational and informational purposes only. Not financial advice. Consult a licensed advisor.